Modeling the risk of radiation-induced acute esophagitis for combined Washington University and RTOG trial 93-11 lung cancer patients

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 5, 2012, Pages 1674-1679

  Huang, Ellen X ^a   Bradley, Jeffrey D ^a   El Naqa, Issam ^a   Hope, Andrew J ^b   Lindsay, Patricia E ^b   Bosch, Walter R ^a   Matthews, John W ^a   Sause, William T ^c   Graham, Mary V ^d   Deasy, Joseph O ^e  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PRINCESS MARGARET HOSPITAL   (Canada)

^c LDS HOSPITAL   (United States)

^d Department of Radiation Oncology   (United States)

^e MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

Acute esophagitis; Lung cancer; NTCP; Radiotherapy

Indexed keywords

ACUTE ESOPHAGITIS; CLINICAL PARAMETERS; CLINICAL TRIAL; CONCURRENT CHEMOTHERAPY; CROSS VALIDATION; DATA SETS; DOSE-VOLUME PARAMETERS; EQUIVALENT UNIFORM DOSE; FRACTION SIZE; LOGISTIC ANALYSIS; LOGISTIC FUNCTIONS; LOGISTIC MODELS; LUNG CANCER; MEAN DOSE; MULTIVARIATE STATISTICAL MODELS; NON SMALL CELL LUNG CANCER; NTCP; OPTIMAL MODEL; PRE-TREATMENT; PREDICTIVE MODELS; RADIATION-INDUCED; SINGLE PARAMETER; STATISTICAL MODELS; STATISTICAL PERFORMANCE; TREATMENT PLANS; TWO PARAMETER; UNIVARIATE; WASHINGTON UNIVERSITY; WEIGHT LOSS;

BIOLOGICAL ORGANS; CHEMOTHERAPY; DISEASES; MODEL BUILDINGS; MULTIVARIANT ANALYSIS;

RADIOTHERAPY;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER RADIOTHERAPY; COHORT ANALYSIS; COMPARATIVE STUDY; DOSIMETRY; ESOPHAGITIS; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PREDICTIVE VALUE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RISK ASSESSMENT; RISK FACTOR; UNIVERSITY HOSPITAL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, NON-SMALL-CELL LUNG; COHORT STUDIES; ESOPHAGITIS; ESOPHAGUS; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; RADIATION INJURIES; RADIOTHERAPY DOSAGE; RISK; SEX FACTORS; TUMOR BURDEN; WEIGHT LOSS;

EID: 84858709551     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2011.02.052     Document Type: Article

References (27)

1. Bradley J, Movsas B. Radiation esophagitis: Predictive factors and preventive strategies. Semin Radiat Oncol 2004;14:280-286. (Pubitemid 39536022)
2. Bradley J, Deasy JO, Bentzen S, et al. Dosimetric correlates for acute esophagitis in patients treated with radiotherapy for lung carcinoma. Int J Radiat Oncol Biol Phys 2004;58:1106-1113. (Pubitemid 38314792)
3. Ahn SJ, Kahn D, Zhou Z, et al. Dosimetric and clinical predictors for radiation-induced esophageal injury. Int J Radiat Oncol Biol Phys 2005;61:335-347. (Pubitemid 40164425)
4. Choy H, AkerleyW, Safran H, et al. Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer. J Clin Oncol 1998;16:3316-3322. (Pubitemid 28481627)
5. Belderbos J, Heemsbergen W, Hoogeman M, et al. Acute esophageal toxicity in non-small cell lung cancer patients after high dose conformal radiotherapy. Radiother Oncol 2005;75: 157-164. (Pubitemid 40805244)
6. Chapet O, Kong FM, Lee JS, et al. Normal tissue complication probability modeling for acute esophagitis in patients treated with conformal radiation therapy for non-small cell lung cancer. Radiother Oncol 2005;77:176-181. (Pubitemid 41682384)
7. Patel AB, Edelman MJ, Kwok Y, et al. Predictors of acute esophagitis in patients with non-small-cell lung carcinoma treated with concurrent chemotherapy and hyperfractionated radiotherapy followed by surgery. Int J Radiat Oncol Biol Phys 2004;60:1106-1112. (Pubitemid 39440795)
8. Rose J, Rodrigues G, Yaremko B, et al. Systematic review of dose-volume parameters in the prediction of esophagitis in thoracic radiotherapy. Radiother Oncol 2009;91:282-287.
9. Kahn D, Zhou S, Ahn SJ, et al. "Anatomically-correct" dosimetric parameters may be better predictors for esophageal toxicity than are traditional CT-based metrics. Int J Radiat Oncol Biol Phys 2005;62:645-651.
10. Wei X, Liu HH, Tucker SL, et al. Risk factors for acute esophagitis in non-small-cell lung cancer patients treated with concurrent chemotherapy and three- dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2006;66:100-107. (Pubitemid 44175670)
11. Qiao WB, Zhao YH, Zhao YB, et al. Clinical and dosimetric factors of radiation-induced esophageal injury: Radiation-induced esophageal toxicity. World J Gastroenterol 2005;11: 2626-2629.
12. Singh AK, Lockett MA, Bradley JD. Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2003;55:337-341. (Pubitemid 36069091)
13. Kim TH, Cho KH, Pyo HR, et al. Dose-volumetric parameters of acute esophageal toxicity in patients with lung cancer treated with three-dimensional conformal radiotherapy. Int J Radiat Oncol Biol Phys 2005;62:995-1002.
14. Choy H, LaPorte K, Knill-Selby E, et al. Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer. Semin Radiat Oncol 1999;9:90-96. (Pubitemid 29190417)
15. Werner-Wasik M, Langer C, Movsas B. Amifostine in chemoradiation therapy for non-small cell lung cancer: Review of experience and design of a phase II trial assessing subcutaneous and intravenous bolus administration. Semin Oncol 2005;32: S105-S108.
16. Maguire PD, Sibley GS, Zhou SM, et al. Clinical and dosimetric predictors of radiation-induced esophageal toxicity. Int J Radiat Oncol Biol Phys 1999;45:97-103. (Pubitemid 29380080)
17. Rosenman JG, Halle JS, Socinski MA, et al. High-dose conformal radiotherapy for treatment of stage IIIA/IIIB non-small-cell lung cancer: Technical issues and results of a phase I/II trial. Int J Radiat Oncol Biol Phys 2002;54:348-e56.
18. Takeda K, Nemoto K, Saito H, et al. Predictive factors for acute esophageal toxicity in thoracic radiotherapy. Tohoku J Exp Med 2006;208:299-306.
19. Takeda K, Nemoto K, Saito H, et al. Dosimetric correlations of acute esophagitis in lung cancer patients treated with radiotherapy. Int J Radiat Oncol Biol Phys 2005;62:626-629. (Pubitemid 40789937)
20. Hirota S, Tsujino K, Endo M, et al. Dosimetric predictors of radiation esophagitis in patients treated for non-small-cell lung cancer with carboplatin/paclitaxel/radiotherapy. Int J Radiat Oncol Biol Phys 2001;51:291-295. (Pubitemid 32884274)
21. Langer CJ, Movsas B, Hudes R, et al. Induction paclitaxel and carboplatin followed by concurrent chemoradiotherapy in patients with unresectable, locally advanced non-small cell lung carcinoma: Report of Fox Chase Cancer Center study 94-001. Semin Oncol 1997;24(4 Suppl 12):S12-S89-S12-95.
22. Werner-Wasik M, Yorke E, Deasy J, et al. Radiation dose-volume effects in the esophagus. Int J Radiat Oncol Biol Phys 2010;76(3 Suppl):S86-S93.
23. Werner-Wasik M, Swann RS, Bradley J. Increasing tumor volume is predictive of poor overall and progression-free survival: Secondary analysis of the Radiation Therapy Oncology Group 93-11 phase I-II radiation dose-escalation study in patients with inoperable non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 2008;70:385-390.
24. Deasy JO, Blanco AI, Clark VH. CERR: A computational environment for radiotherapy research. Med Phys 2003;30: 979-985. (Pubitemid 36578702)
25. El Naqa I, Bradley J, Blanco AI, et al. Multivariable modeling of radiotherapy outcomes, including dose-volume and clinical factors. Int J Radiat Oncol Biol Phys 2006;64: 1275-1286.
26. Deasy JO, Bentzen SM, Jackson A, et al. Improving normal tissue complication probability models: The need to adopt a "data-pooling" culture. Int J Radiat Oncol Biol Phys 2010; 76(3 Suppl):S151-S1514.
27. Deasy JO, El Naqa I. Image-based modeling of normal tissue complication probability for radiotherapy. Cancer Treat Res 2008;139:215-256.